Pharmacological safety in renal insufficiency:Post-pyelolithotomy patient with pre-existing renal insufficiency - the key is to avoid nephrotoxic analgesics.
NSAIDs mechanism of nephrotoxicity:NSAIDs inhibit COX $\Rightarrow$ decreased prostaglandins (PGE2, PGI2) $\Rightarrow$ afferent arteriolar vasoconstriction $\Rightarrow$ reduced GFR $\Rightarrow$ worsening renal function.
All three NSAIDs listed (diclofenac, naproxen, indomethacin) are therefore
contraindicated:
- Diclofenac: selective COX-2 inhibitor, but still nephrotoxic
- Naproxen: non-selective COX inhibitor, nephrotoxic
- Indomethacin: most potent NSAID, most nephrotoxic
Acetaminophen (Paracetamol):Acts via central COX-3 pathway & endocannabinoid system. Does NOT reduce renal prostaglandins. Safe for use in CKD/renal insufficiency at appropriate doses. Recommended by multiple nephrology guidelines as the preferred analgesic in renal disease.
\[\boxed{\text{Acetaminophen (Option D)}}\]